Results 201 to 210 of about 768,450 (337)

Electrophysiology Models for End-Stage Renal Disease Maladaptations That Promote Asystole. [PDF]

Rev Cardiovasc Med
Chinyere IR.
europepmc   +1 more source

End-stage renal disease: mortality and prognostic factors in 72 Algerian patients.

, 2017
Mourad Raiah, Aicha Henien Djelloul Saiah, Soumia Benilha, Hachemi Zeghar   +3 more
openalex   +1 more source

Rapid Electronic Capturing of Patient-Reported Outcome Measures in Older Adults With End-Stage Renal Disease: A Feasibility Study

, 2020
Jennifer Gabbard, Christopher J. McLouth, Gretchen Brenes, Sophie E. Claudel, Samantha Ongchuan, John Burkart, Nicholas M. Pajewski, Kathryn E. Callahan, Jeff D. Williamson, Mariana Murea   +9 more
openalex   +2 more sources

End-stage renal disease after bariatric surgery [PDF]

, 2008
Deidra C. Crews, Derek M. Fine, Lorraine C. Racusen   +2 more
openalex   +1 more source

Aspects of immune dysfunction in end-stage renal disease.

American Society of Nephrology. Clinical Journal, 2008
Sawako Kato, M. Chmielewski, H. Honda, R. Pecoits-Filho, S. Matsuo, Y. Yuzawa, A. Tranaeus, P. Stenvinkel, B. Lindholm   +8 more
semanticscholar   +1 more source

Diabetes mellitus and end-stage renal disease

Saudi Journal of Kidney Diseases and Transplantation, 2018
Seyed Majid Mousavi Movahhed, Seyed Seifollah Beladi Mousavi, Samaneh Akbarpour   +2 more
doaj   +1 more source

UCP2 Upregulates ACSL3 to Enhance Lipid Droplet Release from Acinar Cells and Modulates the Sirt1/Smad3 Pathway to Promote Macrophage‐to‐Myofibroblast Transition in Chronic Pancreatitis

Advanced Science, EarlyView.
These findings suggest that UCP2 promotes LD formation and release in acinar cells by upregulating ACSL3 expression. This alteration in the local lipid metabolic environment indirectly drives the MMT process. Additionally, UCP2 may regulate the acetylation of Smad3 through Sirt1, enhancing its nuclear activity and activating the TGF‐β/ Smad3 signaling ...
Kunpeng Wang, Lilong Zhang, Beiying Deng, Wanrong Jiang, Tianrui Kuang, Chen Chen, Kailiang Zhao, Qiao Shi, Jun He, Weixing Wang   +9 more
wiley   +1 more source

Outcomes of End Stage Renal Disease in Patients With Infective Endocarditis: A Nationwide Population-Based Study. [PDF]

J Am Heart Assoc
Hung HC, Chang FC, Hsieh MJ, Chen CY, Cheng YT, Lin CP, Chen DY, Tung YC, Hung KC, Chen SW.   +9 more
europepmc   +1 more source

Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease—A Propensity Score Analysis

, 2015
Shunya Uchida, Wenxiu Chang, Tatsuru Ota, Yoshifuru Tamura, Takeshi Shiraishi, Takanori Kumagai, Shigeru Shibata, Yoshihide Fujigaki, Makoto Hosoyamada, Kiyoko Kaneko, Zhong Yang Shen, Shin Fujimori   +11 more
openalex   +2 more sources

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

Journal of the American Medical Association (JAMA), 2011
T. Isakova, Huiliang Xie, Wei Yang, D. Xie, A. Anderson, J. Scialla, P. Wahl, O. Gutiérrez, S. Steigerwalt, Jiang He, S. Schwartz, J. Lo, A. Ojo, J. Sondheimer, Chi-yuan Hsu, J. Lash, M. Leonard, J. Kusek, H. Feldman, M. Wolf   +19 more
semanticscholar   +1 more source